Phathom Pharmaceuticals, Inc. Quarterly Interest Expense in USD from Q3 2018 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Phathom Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2018 to Q2 2024.
Phathom Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2024 was $17.8M, a 84.8% increase year-over-year.
Phathom Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2024 was $58.1M, a 54% increase year-over-year.
Phathom Pharmaceuticals, Inc. annual Interest Expense for 2023 was $42M, a 53.7% increase from 2022.
Phathom Pharmaceuticals, Inc. annual Interest Expense for 2022 was $27.3M, a 302% increase from 2021.
Phathom Pharmaceuticals, Inc. annual Interest Expense for 2021 was $6.79M, a 48.2% increase from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$58.1M	$17.8M	+$8.15M	+84.8%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$49.9M	$17.2M	+$7.95M	+86.3%	Jan 1, 2024	Mar 31, 2024	10-Q/A	2024-06-14
Q4 2023	$42M	$13M	+$3.43M	+35.7%	Oct 1, 2023	Dec 31, 2023	10-K/A	2024-06-14
Q3 2023	$38.5M	$10.1M	+$830K	+8.95%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$37.7M	$9.62M	+$3.95M	+69.7%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	$33.8M	$9.22M	+$6.46M	+234%	Jan 1, 2023	Mar 31, 2023	10-Q/A	2024-06-14
Q4 2022	$27.3M	$9.6M	+$6.83M	+246%	Oct 1, 2022	Dec 31, 2022	10-K/A	2024-06-14
Q3 2022	$20.5M	$9.28M	+$7.79M	+525%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$12.7M	$5.67M	+$4.41M	+351%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	$8.28M	$2.76M	+$1.49M	+117%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-10
Q4 2021	$6.79M	$2.78M	+$1.48M	+114%	Oct 1, 2021	Dec 31, 2021	10-K	2023-02-28
Q3 2021	$5.31M	$1.49M	+$199K	+15.5%	Jul 1, 2021	Sep 30, 2021	10-Q/A	2022-11-09
Q2 2021	$5.11M	$1.26M	-$6K	-0.48%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-02
Q1 2021	$5.12M	$1.27M	+$534K	+72.4%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	$4.58M	$1.3M	+$256K	+24.6%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-01
Q3 2020	$4.33M	$1.29M	-$704K	-35.4%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-08
Q2 2020	$5.03M	$1.26M	+$125K	+11%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-10
Q1 2020	$4.9M	$738K	+$727K	+6609%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q4 2019	$4.18M	$1.04M			Oct 1, 2019	Dec 31, 2019	10-K	2021-03-30
Q3 2019		$1.99M	-$2.01M	-50.3%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-10
Q2 2019		$1.14M			Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019		$11K			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-12
Q3 2018		$4M			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.